Growing up in California, wellness was treated almost as a civic religion. Among friends, it was frequently a source of lighthearted jokes, where products like Evian water and fat-free frozen yogurt served as easy punch lines, and crystals were inherently funny—traits that many might argue persist to this day. Yet beneath all that casual eye-rolling and skepticism, an underlying idea was quietly absorbed almost without noticing: the choices made each day, ranging from dietary habits to physical activity, fundamentally shape how well a person lives.
That modest realization seems almost quaint today. The modern landscape has shifted dramatically, and the historical line between everyday wellness and advanced clinical medicine is increasingly blurred. Nowhere is this convergence more evident than in the rapidly expanding, high-stakes longevity industry. At the heart of this booming sector lies a single, driving question that overshadows all others: Exactly how much control can human beings exert over the way they age? That pressing inquiry forms the conceptual cornerstone of a landmark publication—Robb Report’s very first dedicated wellness issue.
The Genetic Lottery and the Allure of Klotho
In a major feature for the new issue, editor at large Mark Ellwood explores one potential answer to the puzzle of aging, embarking on a journey that begins with a simple blood test and yields an entirely unexpected piece of good news. Rather than uncovering a hidden disease risk or an ominous biological marker, Ellwood learns that he carries the KL-VS genetic variant. This specific genetic profile helps the human body produce higher levels of Klotho, a specialized protein that has become a subject of intense scientific interest due to its strong association with healthier, more resilient aging.
While academic and clinical researchers study the protein’s potential to protect the brain, cardiovascular system, and other vital organs as individuals grow older, the commercial longevity sector has seized upon the discovery with remarkable speed. Experimental Klotho-based treatments and therapies are already commercially available abroad, with price tags that reach well into six figures. Armed with what he calls a genetic jackpot, Ellwood sets out to discover whether this protein might genuinely change the way humans age, or if the multi-billion-dollar longevity sector has simply found yet another sophisticated way to package and sell an ancient, elusive fantasy.
The Darker Side of Optimization: Longevity-Fixation Syndrome
While the promise of extended youth captivates millions, the relentless pursuit of a longer life can occasionally take a much darker, psychologically taxing turn. Staff writer Tori Latham examines the emergence of longevity-fixation syndrome, an unofficial diagnosis that describes a very real and increasingly prevalent modern problem: individuals who become so utterly consumed with the idea of living longer that their mental health, emotional well-being, and personal relationships begin to suffer profound consequences.
What typically begins as a reasonable, health-conscious desire to prevent disease and maintain vitality can gradually escalate into a compulsive cycle. Sufferers often subject themselves to constant, exhausting biological testing and adopt rigid, unforgiving daily routines built around an ever-expanding roster of dietary supplements and experimental medical remedies. The early warning signs can be deceptively easy to miss, largely because the obsessive behavior often masquerades as high-level personal discipline and dedication. However, once the regimen begins to aggressively crowd out the rest of a person’s life, the obsession can cause genuine psychological and social harm. As one physician pointed out to Latham during her reporting, it is entirely possible for a person to effectively "optimize the life out of your life."
Testing the Industry’s Promises Firsthand
To truly understand what the modern longevity sector offers beyond marketing claims, Robb Report decided to test its promises firsthand. A team of five magazine writers checked into several of the world’s leading wellness retreats and advanced medical clinics to experience the treatments themselves and report on what they actually deliver.
The writers submitted to a grueling array of experimental and alternative therapies, ranging from blood washing and cryotherapy clinics in Germany to ozone infusions and specialized sessions inside a Human Regenerator machine in Mexico. Their collective mission was straightforward yet demanding: to report candidly and objectively on the experiences, carefully weighing any perceived physiological benefits against the hefty investments of time and financial resources required.
Their firsthand accounts reveal the extraordinary lengths to which people are willing to go—and the staggering amounts of money they are prepared to spend—in the fervent hope of living better, healthier lives for a longer duration. While some treatments produced noticeable, positive differences in energy and recovery, others ultimately raised significantly more questions than answers.
Yet, as the reporting demonstrates, one overarching reality has become undeniably clear. Within a global wellness economy that is projected to reach nearly $8 trillion this year, longevity has officially transformed into serious business, and for the millions investing in their futures, no one is joking anymore.
